PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ANAMORELIN HCL

Administered By

Awarded By

Contributors

Start/End

  • May 9, 2019 - May 31, 2024